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The determination of an amino acid substitution in the “core” region of abnormal hemoglobin 
is technically difficult and is time- and labor-intensive both by conventional and by mass 
spectrometry techniques. Underivatized subunits cleaved with trypsin and lysyl endopepti- 
dase were analyzed by high-performance liquid chromatography-electrospray ionization- 
mass spectrometry. The core peptides showed a series of multiply charged ions of homo- and 
heterodimers. Abnormal peptides in the core region could be detected in dimeric form. The 
sequence of core peptides was determined by product ion spectra of the peptides from 
oxidized globin digested with trypsin and lysyl endopeptidase. Oxidation of cysteine residues 
to cysteic acids in the core region resulted in the strong promotion of y-series ions by product 
ion analysis with a tryptic peptide from apoprotein B-100 as previously reported by Burlet, 
Yang, and Gaskell (J. Am. Sot. Mass Spectrom. 1992, 3,337-344). These techniques were used 
to prove that substitution of an unstable hemoglobin, known as Hb Santa Ana (p88 
leucine + proline), occurred in a patient with congenital hemolytic anemia. The tandem 
mass spectrometry analysis with oxidized globin digested with trypsin and lysyl endopepti- 
dase offers a novel method to detect substitutions in the core region of hemoglobin. (J Am Sot 
Mass Spectrom 2996, 7, 1040-1049) 
M any known hemoglobin variants are associ- ated with apparent clinical manifestations, such as anemia, polycythemia, cyanosis and 
thrombosis, some of which are life-threatening [ll. 
Variant hemoglobin detection and identification are 
clinically important. However, identification of the 
variants usually requires complex and time-consuming 
chemical analysis. Since the 1981 pioneer work on 
variant identification introduced by Wada et al. [2] 
who used field desorption mass spectrometry, the pro- 
cedures have been improved by secondary ion [3-51 or 
fast-atom bombardment 16, 71 mass spectrometry, and 
most recently by electrospray ionization (ES11 mass 
spectrometry 18-101 and tandem mass spectrometry 
111-131. However, in the case of amino acid substitu- 
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tion in the “core” region of hemoglobin, the determi- 
nation is rather complicated and time-consuming, even 
with these improved mass spectrometry techniques. 
Under the basic condition of tryptic digestion and also 
during preparation, the cysteine -SH group is oxi- 
dized to the disulfide, which forms homo- or het- 
erodimeric molecules. We have reported previously 
[13] that the assignment of the ions in the electrospray 
ionization-mass spectrometry (ESI-MS) spectra of the 
tryptic digest of the nonderivatized globin, which cov- 
ers the whole sequence of the c1- and P-subunits, may 
offer a rapid diagnostic method to detect amino acid 
substitutions in the noncore region. For core peptides, 
it is possible to detect an ion of abnormal dimeric 
peptides by the difference of mass values. However, 
dimer peptides are hard to analyze by tandem mass 
spectrometry. For determination of amino acid substi- 
tutions, cysteine is derivatized by aminoethylation I.81 
or carboxyamidomethylation [141 for analysis by mass 
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spectrometry. By aminoethylation, however, some 
tryptic peptides may be too small for mass spectrome- 
try analysis. Some of the reagents for alkylation are 
carcinogenic and unstable under routine laboratory 
conditions, and because the buffers for the alkylation 
are not volatile, it takes rather a long time to remove 
the buffer and excess reagents. 
Burlet and co-workers [15, 161 reported that oxida- 
tion of cysteine residues to cysteic acids in a tryptic 
peptide from apoprotein B-100 resulted in the strong 
promotion of y-series ions, and both the absolute 
and relative abundances of this fragment type were 
increased in the measurement by hybrid sector- 
quadrupole instruments that involve low collision en- 
ergy. They explained that the formation of multiple 
numbers of the y,, series of ions (nomenclature for 
fragment ions according to Bieman [17]) is promoted 
by a gas-phase interaction between the C-terminal ba- 
sic amino acid residues and cysteic acid residues, which 
reduces the propensity for protonation exclusively at 
the C-terminal arginine or lysine. The oxidation of 
globin may be suitable for the determination of amino 
acid substitutions in the core region by tandem mass 
spectrometry analysis. The reagents for oxidation (for- 
mic acid and hydrogen peroxide), are removed easily 
by evaporation. If we can obtain reliable spectra by 
tandem mass spectrometry with oxidized peptides, 
performic acid oxidation might be the best choice of 
derivatization method for core peptides. Herein, we 
analyzed the peptides from oxidized globin by triple- 
stage quadrupole mass spectrometry. To obtain high 
yields of core region peptides, globin or its subunits 
were cleaved with both trypsin and lysyl endopep- 
tidase, which cleaves the C-terminal amide bond 
of lysine and the bonds resistant to trypsin, such as 
the bond between lysine and aspartic acid or the C- 
terminal bond of Asp-Lys [18]. By this improved pro- 
cedure, we determined an amino acid substitution in 
the core region of an abnormal hemoglobin that had 
the same structure as I-lb Santa Ana ( p88 leucine -+ 
proline) [ 191. 
Experimental 
Materials 
Hemoglobin was obtained from normal healthy adults 
and from a Japanese patient with congenital hemolytic 
anemia. 
Preparation of pep tides 
The hemoglobin solution and globin were prepared by 
the method previously described [20-221. The normal 
and abnormal @ubunits were separated by high- 
performance liquid chromatography (HPLC) in accor- 
dance with the report of Schroeder et al. [23] by using 
a 4.6~mm X 250-n-m reverse phase column !Vydac C,>. 
The gradients were formed between solvent A (8: 2 
mixture of aqueous 0.1% trifluoroacetic acid and 0.1% 
trifluoroacetic acid in acetonitrile) and B (these solu- 
tions in a ratio of 1: 9). The flow rate was 1 mL min-‘. 
Globin was oxidized at -5 “C with performic acid in 
accordance with the method of Hirs [241. 
The peptides were prepared by tryptic digestion 
alone and by cleavage with combinations of two en- 
zymes. One combination was trypsin and lysyl en- 
dopeptidase and the other was trypsin and V8 pro- 
tease. Intact globin was cleaved with trypsin in 0.1-M 
ammonium bicarbonate (pH 8.4) for 24 h. Oxidized 
globin or intact @chain were cleaved with try-psin and 
lysyl endopeptidase in 0.1-M ammonium bicarbonate 
(pH 8.4). After tryptic digestion for 1 h at 37 “C, lysyl 
endopeptidase was added to the reaction mixture, 
which was incubated for an additional 23 h at 37 “C. 
For the combination of trypsin and V8 protease, pro- 
tein was cleaved with try+n in 0.1-M ammonium 
bicarbonate (pH 8.4) for 24 h and the reaction mixture 
was lyophilized. V8 protease was then added to the 
tryptic digests dissolved in 0.1-M ammonium bicar- 
bonate (pH 8.8) and digestion was continued for an 
additional 24 h at 37 “C. For each enzyme, the concen- 
tration of the protein was 1 mg mL-’ and the ratio of 
enzyme to protein was 1: 100 (w/w). The reaction 
mixture was lyophilized and redissolved in distilled 
water; this step was repeated four times to remove 
trace amounts of ammonium bicarbonate. For prep- 
aration of samples, - 0.1 mL of blood was used and 
100 mg of lyophilized globin or separated subunit 
was digested with the enzymes. L-(tosylamido 2- 
phenyl) ethyl-chloromethyl ketone UPCK) trypsin was 
purchased from Worthington Biochemical Corp. 
(Freehold, NJ; lot 33K996). Lysyl endopeptidase from 
Achromobacter Zyticus was purchased from Wako Pure 
Chemical Industries (Osaka, Japan; lot YLR9326). Pro- 
tease V8 from Staphylococcus aureus was purchased 
from ICN Biomedicals Inc. (Costa Mesa CA; lot 035A). 
Mass Spectrometry 
ES1 mass spectra were obtained on a TSQ-7000 triple- 
stage quadrupole mass spectrometer (Finnigan MAT, 
San Jose, CA) equipped with an electrospray ion source. 
Samples were introduced into the ion sources by infu- 
sion with a Harvard Apparatus (South Natick, MA) 
pump by using a solvent of 50% methanol in water 
that contained 1% (v/v) acetic acid, at a flow rate 
of 3 ILL min- ‘. The amount of digest consumed for 
each analysis was 100 mL of - 10 pmol FL-’ (the 
- 10 pmol corresponds to - 320 ng of globin and 
- 160 ng of @subunit) in the methanol (50%) and 
acetic acid (2%) solution. Intact globin also was ana- 
lyzed with the same amount dissolved in the same 
solution. 
Digests also were applied to a microcapillary 
column connected to the ion source. A silica-based 
microcapillary HPLC column (Vydac C,,, 0.5 mm x 
150 mm; 300 A; 5 mm; Michrom Bioresources Inc., 
lo& NAKANISHl lX AL. 
Pleasanton, CA) was used. Peptides dissolved in 
acetonitrile-water (2 : 98) that contained 0.1% trifluo- 
roacetic acid were injected and were eluted with a 
gradient of 2-55% acetonitrile that contained 0.08% 
trifluoroacetic acid over 45 min at a flow rate of 
50 PL min-‘. For each liquid chromatography-mass 
spectrometry (LC-MS) analysis, 10 PL of m 10 pmol 
pL-* (the N 10 pmol corresponds to m 160 ng of 
p-chain) was injected. 
For ESI-MS, the scanning range was’ M/Z 50-2500 
in 3 s and the octapole offset potential was set at 3 V. 
Intact globin and tryptic peptides of unde- 
rivatized globin mixture from infusion and peptides of 
underivatized normal and abnormal P-subunits 
cleaved by trypsin and lysyl endopeptidase through 
HFLC were analyzed by using the foregoing scanning 
conditions. Digests of oxidized globin were analyzed 
by tandem mass spectrometry by using the system 
HPLC-ESI-MS-CID-MS (collision-induced dissocia- 
tion mass spectrometry). To measure the product ion 
spectra, the precursor peak width was increased to 
m/z - 4, and the collision cell voltage was set at 
30-55 V; the scanning range was m/z 50-2500 for the 
second mass analyzer and the octapole offset potential 
was set as before. For ion fragmentation in the electro- 
spray source [WI, the scanning range and time were 
the same as normal scanning stated previously and the 
o&pole offset potential was set at 15-25 V. Calibra- 
tion was performed by using the peptide Met-Arg- 
Phe-Ala and horse apo-myoglobin for all procedures. 
The structure of the peptides was assigned by tandem 
mass spectra, in accordance with the principles intro- 
duced by Hunt et al. [26], by using a program named 
Peptide Matching and Interpretation (ICIS and Biotech, 
Version 8.0, Finnigan MAT). In tandem mass spectra, 
the minimum acceptable signal-to-noise ratio was set 
at 3. The amino acid sequence of normal hemoglobin 
and the nomenclature of the tryptic peptides were 
according to Hilse and Braunitzer [27] and Guidotti et 
al. i-281 ( PT indicates the tryptic peptide of the sub- 
unit; the number is the order from the amino terminus 
in the present paper). 
Results 
Figure 1 shows a deconvoluted spectrum from a mass- 
to-charge ratio spectrum of globin prepared from a 
patient with congenital hemolytic anemia. The ion of 
the &subunit prepared from the patient’s blood 
showed a split peak: the average molecular weight of 
one peak was 15854.0 f 1.3 and the other was 15868.3 
f 1.2; the mass difference between the two compo- 
nents was estimated 12-16 u. Therefore, an amino acid 
substitution in the @subunit of the abnormal 
hemoglobin was suspected. The amino acid substitu- 
tion was determined by the following four steps: 
1. ESI-MS of tryptic digests of a mixture of all globins 
((Y, normal, and abnormal p). 
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Figure 1. A mass spectrum deconvoluted from a mass-to-charge 
ratio spectrum of globin prepared from a patient with congenital 
hemolytic anemia. The values are given as the average plus or 
minus standard deviation of the calculated values of each ion. 
2. High-performance liquid chromatography-electro- 
spray ionization-mass spectrometry (HPLC-ESI-MS) 
of separated normal and abnormal p-subunits 
digested with trypsin and lysyl endopeptidase. 
3. High-performance liquid chromatography-elec- 
trospray ionization-tandem mass spectrometry 
(HPLC-ESI-MS/MS) of mixture of all oxidized 
globin. 
4. Electrospray ionization-tandem mass spectrometry 
(ESI-MS/MS) of abnormal P-subunit digested with 
trypsin and V8 protease. 
The first step was for screening. The globin mixture, 
which contained CX- and &subunits from normal and 
abnormal components, were cleaved with trypsin and 
the peptides were analyzed by ESI-MS by sample 
loading through an infusion pump. Abnormal peptides 
could not be found at this step. All peptides except the 
core region showed the expected mass-to-charge ratio 
values. In the case of substitution in a noncore region, 
abnormal peptides should be detected in this step as 
we reported previously 1131. In the second step, the 
separated normal and abnormal @subunits that were 
not oxidized were cleaved with trypsin and lysyl en- 
dopeptidase and the digests were analyzed by ESI-MS 
through a microcapillary HPLC. A series of ions of 
multiply charged pT10 and pT12 homodimers and 
pTlO-PT12 heterodimer were observed in mass chro- 
matograms obtained by LC-MS of peptides of normal 
&subunits (Figure 2a). Singly charged ions of dimer 
peptides were outside the scanning range of up to m/z 
2500. The mass-to-charge ratio of doubly charged ions 
of homodimers and singly charged ions of monomer 
peptides were slightly different. Theoretically, the for- 
mer is 1.0 u smaller than the latter. Observation of the 
series of multiply charged ions shown in the insets of 
Figure 2 confirms that these ions are generated from 
dimer peptides. The mass chromatograms of digests of 
abnormal @-subunits showed ion peaks of pT12 ho- 
modimer, but no ion peaks of /3TlO homodimer or 
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Figure 2. Reconstructed selected ion chromatograms and total 
ion chromatogram by microcapillary HPLC-ESI-MS of peptides 
digested with trypsin and lysyl endopeptldase from underiva- 
tized Psubunits of an abnormal hemoglobin in comparison with 
normal counterparts. The ions of interest were selected from the 
total ion chromatogram. (a) normal control. Traces for selected 
ions, m/z 1421.0 f 0.3 for doubly charged pT10 dimers, m/z 
1570.8 f 0.3 for doubly charged heterodimer of PTlO and p T12, 
and m/z 1719.8 f 0.3 for doubly ‘charged PT12 dimers are 
shown. By the analysis of peptides from abnormal psubunit, the 
former two ions were not detected. Therefore, the ions that 
correspond to 12-16 u less than the normal counterparts were 
plotted. (b) The abnormal ion peaks at m/z 1405.5 f 0.3 for 
doubly charged abnormal PTlO dimer and m/t 1563.5 + 0.5 for 
doubly charged abnormal PT*lO and normal /IT12 connected by 
a disulfide bridge. The scale of the relative abundance for the 
selected ions is normalized in the chromatogram of each selected 
ion. The ES1 spectra of each peak marked by an arrow are shown 
in insets. 
pTlO-PT12 heterodimer. The search by mass chro 
matography to find ion peaks of 12-16 u less than the 
normal pT10 peak revealed a prominent ion peak of 
abnormal /3 TlO ( j3 T*lO), which was 16 u less than the 
normal PTlO peak. These mass chromatograms are 
shown in Figure 2b. 
In the third step, the mixture of globin derived from 
a normal individual and globin from a patient who 
carried a variant were oxidized by performic acid and 
cleaved with trypsin and lysyl endopeptidase. The 
peptides that contained cysteic acids were analyzed by 
microcapillary HPLC-ESI-MS/MS. Figure 3 shows 
mass chromatograms from microcapillary HFLC-ESI- 
MS analysis of peptides digested with trypsin and 
lysyl endopeptidase from an oxidized mixture of 
globins derived from a patient. Singly charged ions of 
oxidized peptides of /3T*lO, pT10, and j3 T12, and 
doubly charged ion of oxidized olT12 were monitored. 
The ions at m/z 1509-1510 for olT12, at m/z 1470-1471 
for /3TlO, and at m/z 1768.5-1769.5 for pT12 were 
found in both the normal and the abnormal cases, but 
the ion at m/z 1454-1455, which corresponds to the 
singly charged ion of oxidized /3T*lO, was found only 
in the abnormal case. 
Figure 4 shows the product ion spectra of these 
ions. Doubly charged precursor ions, m/z 727.4 and 
735.8 were used for collision-induced dissociation (CID) 
spectra measurements. The y-series ions were rela- 
tively clear in these spectra. The product ion spectrum 
of m/z 735.8 (which corresponds to singly charged 
1470.6; Figure 4a) indicated an assignment to oxidized 
PTlO of normal globin. The product ion spectra of 
precursor ions at m/z 735.8 (Figure 4a) and 727.4 
(Figure 4b) included common y ions below m/z 880 
(i.e., yi-y,). These ions correspond to the y ions that 
show the sequence ( p 89-95) Ser-Glu-Leu-His-cysteic 
i I::,., i 
Figure 3. Reconstructed selected ion chromatograms of mi- 
crocapillary HPLC-ESI-MS of peptides digested with trypsin 
and lysyl endopeptidase from oxidized globin derived from 
a patient who carries a mixture of normal and abnormal hemo- 
globin. The ions of interest were selected from the total ion 
chromatogram. Traces for selected ion, m/z 1454.5 f 0.5 for 
singly charged abnormal oxidized /3T*lO, m/z 1470.5 f 0.5 
for singly charged oxidized normal pT10, m/z 1509.5 f 0.5 for 
doubly charged oxidized normal aTl2, and m/z 1769.0 f 0.5 for 
singly charged oxidized normal p T12 are shown. The scale of the 
relative abundance for the selected ions is normalized in the 
chromatogram of each selected ion. ES1 spectra of each peak 
marked by an arrow are shown in insets. 
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acid-Asp-Lys. The ion ys at m/z 992.5 in the spectrum in the normal spectrum if we subtract 16 u from the 
of normal peptide (Figure 4a) was not observed in the mass number of y-series ions larger than m/z 970 in 
spectrum of the variant peptide (Figure 4b). Instead, a the spectra of normal pT10. These ions show the 
prominent ion was observed at m/z 976.4 in the spec- p85-87 sequence Phe-Ala-Thr. The difference of the 
trum of Figure 4b. The mass difference of these ions two prominent ions of 97.3 u observed in the spectra of 
was 16.1 u. The ions that correspond to yg, ylO, and yr, variant peptide (m/z 976.6 and 879.3) corresponds to 
in the spectrum of the variant were identical to those the proline residue. Therefore, we concluded that the 
b0 Sorir8 1 a 3 4 9 6 7 6 9 10 11 11 13 
Normal 58.0 159.1 m 377.2 478 . 2 591 . 3 670.3 807.4 920.5 1057.5 1208.5 1323.6 1451.7 
Santa Ana 58.0 159.1 w 377.2 178.2 575.3 662.3 791.4 904.4 1041.5.1192.5 1307.5 1435.6 
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Figure 4. Product ion spectra from CID of (a) m/z 735.8, the doubly charged precursor ion of oxidized PTlO (normal), and (b) m/z 
727.4, the doubly charged precursor ion of oxidized P’TIO (abnormal). The top section of the figure shows the proposed amino acid 
sequence and expected yn and b, fragment ion masses; those values underlined were detected in CID spectra. Cys* indicates cysteic 
acid. 
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Figure 4. (Continued) 
leucine at the 88th position of the normal @chain is 
substituted by proline in the hemoglobin we analyzed, 
as in Hb Santa Ana [193. 
The product ion spectrum of the precursor ion at 
m/z 727.4, which corresponds to PT*lO ([M + WI*‘), 
showed a prominent product ion at m/z 976.4 (ys; 
Figure 4b). This ion also could be generated in the ion 
source and we used it for the MS3 experiment (ion 
source CID). Figure 5 shows the product ion spectrum 
of a precursor ion of m/z 976.4 generated by ion 
source CID. The spectrum shows the y,- as well as 
b,-series ions of the abnormal y ion p88-95 (Pro-Ser- 
Glu-Leu-His-cysteic acid-Asp-Lys). It was shown pre- 
viously that fragmentation of the peptide bond that 
involves the proline amino group to yield the corre- 
sponding y ion is more likely to occur than with other 
amino acid residues [26]. 
Abnormal @ubu.nit without oxidation was di- 
gested by trypsin and V8 protease and the digests 
were analyzed by ESI-MS by infusion loading. This 
experiment was performed to confirm the result of 
mass spectrometry analysis with oxidized materials. 
By using the knowledge of the possible substitution 
Leu + Pro at /388 and the specificity of these en- 
zymes, an ion of expected mass was examined selec- 
tively. The mass value and partial information from 
the product ion spectrum of an ion of m/z 809.6 
suggested that the ion corresponded to the peptide 
from amino acid residues 83-90 of the abnormal /3- 
chain. A major product ion of the peptide was at m/z 
331.5 (y3). This ion was obtained by ion source CID 
and was analyzed by tandem mass spectrometry. The 
spectrum showed that the sequence corresponded to 
Pro-Ser-Glu. The spectrum is not shown, but is avail- 
able on request. 
Product ion mass spectra of precursor ions of m/z 
1006.7, a triply charged ion of normal oxidized olT12, 
and m/z 884.7, a doubly charged ion of oxidized 
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Figure 5. Product ion spectrum of a precursor ion of m/z 976.6 obtained by ion source CID. The ion was a product ion of the 
abnormal oxidized peptide /3T*lO as shown in Figure 4b and was generated in the ion source by using a higher octapole offset (20 VI. 
The ion was analyzed by usual CID activation. 
pT12, are shown in Figure 6. The sequence of most 
amino acids in these peptides could be determined 
from the spectra. 
Discussion 
The analysis of nonoxidized peptides by HPLC-ESI-MS 
revealed a dimeric abnormal peptide PT*lO. For se- 
quence determination, the oxidized globin was di- 
gested with trypsin and lysyl endopeptidase and the 
I-IPLC-ESI-MS/MS of the digests clearly showed the 
ions of oxidized peptides in the core region. The frag- 
ment ions of the y series in product ion spectra of 
peptides that contain cysteic acid were prominent as 
previously reported with an apoprotein peptide by 
Burlet et al. [15, 161. Here, this procedure was success- 
fully applied to determine the substitution of leucine 
by proline at the 88th position of P-chain, as seen in 
Hb Santa Ana [191. A fragment ion that represents 
cleavage of the peptide bond that involves the proline 
amino group yielded the corresponding strong y ions 
1261. Fragmentation by application of higher voltage in 
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the intermediate pressure region of the ion source 
enabled the ion with N-terminal proline to be selec- 
ted and analyzed by the usual tandem mass spectrom- 
etry* 
These procedures are rather simple and reliable, 
and to our knowledge, this is the first report of tandem 
mass spectrometry analysis of oxidized peptides for 
determination of the hemoglobin variant. In our exper- 
iment with normal and abnormal hemoglobin, all pep- 
tides that contain cysteic acid, that is, aT12, pT10, and 
a) 
/3 T12, showed strong precursor ions and clear product 
ion spectra. In addition to cysteine, methionine and 
tryptophan also are oxidized by the conditions we 
employed. These three core region peptides do not 
contain methionine or tryptophan. The abundance of 
ions of peptides that contain oxidized methionine (aT5, 
aT9, and pT5) were strong and the CID spectra also 
clearly showed the y-series ions. The oxidation of tryp- 
tophan may result in the formation of a heterogeneous 
structure of tryptophan-containing peptides. Therefore, 
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Figure 6. Product ion spectra from CID of (a) m/z 1006.7, the triply charged precursor ion of normal oxidized aT12, and (b) m/z 
884.7, the doubly charged precursor ion of oxidized /3 Tl2. 
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Figure 6. (Continued) 
for structural study of the noncore region, peptides 
prepared from nonoxidized globin must be analyzed. 
We have reported that tandem mass spectrometry 
analysis of tryptic peptides of nonderivatized globin is 
suitable for the study of ammo acid substitution [13]. 
However, the quality of product ion spectra of some 
peptides, especially cysteine-containing peptides, was 
not high enough to verify the sequence. The analyses 
of peptides from intact globm and peptides from oxi- 
dized globin are complementary. By the analysis of 
both digests, high quality tandem mass spectra may 
cover the whole sequence of (Y- and /&subunits. 
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